Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 3 (2006), Issue 2 (February)

1. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
   Ann Rheum Dis, 65(3): 405-7. [Abstract] [Full-text]
2. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation.
   Ann Rheum Dis, 65(3): 398-400. [Abstract] [Full-text]
3. Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.
   J Am Acad Dermatol, 54(3): S92-100. [Abstract] [Full-text]
4. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
   J Am Acad Dermatol, 54(3): S85-91. [Abstract] [Full-text]
5. Innate and adaptive immunity and the pathophysiology of psoriasis.
   J Am Acad Dermatol, 54(3): S67-80. [Abstract] [Full-text]
6. Case reports of etanercept in inflammatory dermatoses.
   J Am Acad Dermatol, 54(3): S139-42. [Abstract] [Full-text]
7. Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial.
   J Am Acad Dermatol, 54(3): S112-9. [Abstract] [Full-text]
8. Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
   J Am Acad Dermatol, 54(3): S101-11. [Abstract] [Full-text]
9. Relapse, rebound, and psoriasis adverse events: an advisory group report.
   J Am Acad Dermatol, 54(4): S171-81. [Abstract] [Full-text]
10. Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
    J Am Acad Dermatol, 54(4): S164-70. [Abstract] [Full-text]
11. Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
    J Am Acad Dermatol, 54(4): S154-63. [Abstract] [Full-text]
12. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.
    J Am Acad Dermatol, 54(3): 472-8. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.